Polaris Group
TWSE:6550

Watchlist Manager
Polaris Group Logo
Polaris Group
TWSE:6550
Watchlist
Price: 46.05 TWD -0.97% Market Closed
Market Cap: 35.5B TWD
Have any thoughts about
Polaris Group?
Write Note

EV/EBITDA
Enterprise Value to EBITDA

-17
Current
-54.9
Median
4.3
Industry
Higher than median
Lower than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA
-17
=
Enterprise Value
31.2B TWD
/
EBITDA
-1.8B TWD
All Countries
Close
Market Cap EV/EBITDA
KY
Polaris Group
TWSE:6550
34.3B TWD -17
FR
Pharnext SCA
OTC:PNEXF
6T USD -219 590.5
US
Abbvie Inc
NYSE:ABBV
314.6B USD 15.4
US
Amgen Inc
NASDAQ:AMGN
141.2B USD 16
US
Gilead Sciences Inc
NASDAQ:GILD
117.3B USD 10.3
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
105.4B USD 21.7
US
Epizyme Inc
F:EPE
94.1B EUR -514.5
AU
CSL Ltd
ASX:CSL
136.4B AUD 19.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.4B USD 15.3
US
Seagen Inc
F:SGT
39.3B EUR -58.8
NL
argenx SE
XBRU:ARGX
36.2B EUR -110.1
EBITDA Growth EV/EBITDA to Growth
KY
Polaris Group
TWSE:6550
Average EV/EBITDA: 16.4
Negative Multiple: -17
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 590.5 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.4
9%
1.7
US
Amgen Inc
NASDAQ:AMGN
16
18%
0.9
US
Gilead Sciences Inc
NASDAQ:GILD
10.3
5%
2.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
21.7
13%
1.7
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.5 N/A N/A
AU
CSL Ltd
ASX:CSL
19.9
12%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.3
11%
1.4
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.8 N/A N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -110.1 N/A N/A

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBITDA
N/A
2-Years Forward
EV/EBITDA
N/A
3-Years Forward
EV/EBITDA
N/A

See Also

Discover More